The National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) examine serious side effect, including spinal cord damage of a participant, in COVID-19 vaccine trial that was halted.
AstraZeneca, which is running the global trial of the vaccine it produced with Oxford University, indicated that the volunteer recovered from a severe inflammation of the spinal cord and is no longer hospitalized.
Pfizer Inc to seek Emergency Use Authorization (EUA) approval from the U.S. Food & Drug Administration for its COVID vaccine in November. FDA requires that companies provide two months of safety data on half of trial participants following the final dose of the vaccine.
As with any type of personal protective equipment (PPE), the key to proper selection and use of gowns and coveralls, is to understand the hazards and the risk of exposure.